FDA Grants Emergency Use Authorization for New COVID-19 Vaccine Developed by Janssen with Support from BARDA

[advanced_iframe src=”https://view.connect.hhs.gov/?qs=9c765b9946bebc35137d5984b95ff29feab4ea493f3966bd09bbe873acc55c8c37c62f7b64bc6e9b118cb5f6d6d6a0d93cf3ec15898e70804ae15b8739d5d199f5ffc421a5fbfa63e” width=”100%” height=”2000″]